Literature DB >> 22499776

Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins.

B S Lopes1, S G B Amyes1.   

Abstract

Acinetobacter baumannii is a multi-resistant opportunistic nosocomial pathogen responsible for several outbreaks worldwide. It can cause several infections at various sites of the body. One of the main infections caused by this bacterium is ventilator-associated pneumonia in patients in intensive care units. Treating these infections is becoming difficult because of the high resistance to antimicrobial agents. This study compared the expression of the chromosomally encoded bla(ADC) gene in isolates having ISAba1, ISAba125 and no insertion upstream of the bla(ADC) gene in A. baumannii clinical isolates. It showed that the expression of bla(ADC) was six times greater when ISAba125 was present upstream of the gene in comparison with the constitutively expressed bla(ADC) gene with no insertion present upstream. The study indicated that ISAba125 has better promoters than ISAba1 and this is responsible for the overexpression of the bla(ADC) gene as they share considerable homology to the well-established Escherichia coli promoters. The -10 box of ISAba125 formed a fusion promoter with the -35 box of the bla(ADC) gene causing the bla(ADC) gene to be significantly overexpressed. The ability to upregulate the expression of bla(ADC) with the assistance of different insertion elements such as ISAba1 and ISAba125 has become an important factor in A. baumannii resistance to cephalosporins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22499776     DOI: 10.1099/jmm.0.044156-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  22 in total

1.  Identification of a Novel Plasmid Carrying mcr-4.3 in an Acinetobacter baumannii Strain in China.

Authors:  Furong Ma; Cong Shen; Yong Xia; Guo-Bao Tian; Xiaobin Zheng; Yan Liu; Hongtao Chen; Lanlan Zhong; Yingjian Liang; Kang Liao; Yongqiang Yang
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 2.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

3.  Simultaneous Identification of Multiple β-Lactamases in Acinetobacter baumannii in Relation to Carbapenem and Ceftazidime Resistance, Using Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Hein Trip; Katrin Mende; Joanna A Majchrzykiewicz-Koehorst; Norbert J A Sedee; Albert G Hulst; Hugo-Jan Jansen; Clinton K Murray; Armand Paauw
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

4.  Relative Strengths of Promoters Provided by Common Mobile Genetic Elements Associated with Resistance Gene Expression in Gram-Negative Bacteria.

Authors:  Muhammad Kamruzzaman; Jason D Patterson; Shereen Shoma; Andrew N Ginn; Sally R Partridge; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

Review 5.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

6.  Transposition of Tn125 Encoding the NDM-1 Carbapenemase in Acinetobacter baumannii.

Authors:  Séverine Bontron; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

7.  Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.

Authors:  Deanna Deveson Lucas; Bethany Crane; Amy Wright; Mei-Ling Han; Jennifer Moffatt; Dieter Bulach; Simon L Gladman; David Powell; Jesus Aranda; Torsten Seemann; Diana Machado; Teresa Pacheco; Teresa Marques; Miguel Viveiros; Roger Nation; Jian Li; Marina Harper; John D Boyce
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

8.  Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements.

Authors:  Lingxiang Zhu; Zhongqiang Yan; Zhaojun Zhang; Qiming Zhou; Jinchun Zhou; Edward K Wakeland; Xiangdong Fang; Zhenyu Xuan; Dingxia Shen; Quan-Zhen Li
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

9.  Subtypes, resistance and virulence platforms in extended-drug resistant Acinetobacter baumannii Romanian isolates.

Authors:  Irina Gheorghe; Ilda Czobor Barbu; Marius Surleac; Ionela Sârbu; Laura Ioana Popa; Simona Paraschiv; Yu Feng; Veronica Lazăr; Mariana Carmen Chifiriuc; Dan Oţelea; Zong Zhiyong
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

10.  The Genetic Analysis of an Acinetobacter johnsonii Clinical Strain Evidenced the Presence of Horizontal Genetic Transfer.

Authors:  Sabrina Montaña; Sareda T J Schramm; German Matías Traglia; Kevin Chiem; Gisela Parmeciano Di Noto; Marisa Almuzara; Claudia Barberis; Carlos Vay; Cecilia Quiroga; Marcelo E Tolmasky; Andrés Iriarte; María Soledad Ramírez
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.